Diversity of gastric carcinogenesis: President lecture

Oncology

Volumn 69, Issue SUPPL. 1, 2005, Pages 1-8

  Kaminishi, Michio ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Carcinogenesis; Chemoprevention; Diversity; Gastric cancer; Inflammation

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TROGLITAZONE; TUMOR NECROSIS FACTOR ALPHA;

CANCER INCIDENCE; CANCER RESEARCH; CONFERENCE PAPER; CYTOKINE RELEASE; DISEASE ASSOCIATION; GASTRITIS; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; STOMACH CARCINOGENESIS; STOMACH CARCINOMA;

ANIMALS; GASTRITIS; HELICOBACTER INFECTIONS; HUMANS; INFLAMMATION; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PRECANCEROUS CONDITIONS; SEX CHARACTERISTICS; STOMACH NEOPLASMS;

EID: 26444495516     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086624     Document Type: Conference Paper

References (28)

1. Japanese Gastric Cancer Association: Japanese Classification of Gastric Carcinoma, 2nd English Edition. Gastric Cancer 1998;1:10-24.
2. Lauren P: The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma: an attempt at a histoclinical classification. Acta Pathol Microbiol Scand 1965;64:31-49.
3. Nakamura K, Sugano H, Takagi K: Carcinoma of the stomach in incipient phase: its histogenesis and histological appearances. Gann 1968;59:251-258.
4. Ming SC: Gastric carcinoma. A pathological classification. Cancer 1977;39:2475-2485.
5. Tatematsu M, Ichinose M, Miki K: Gastric and intestinal phenotypic expression of human stomach cancers as revealed by pepsinogen immunohistochemistry and mucin histochemistry. Acta Pathol Jpn 1990;40:494-504.
6. Tahara E: Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol 1993;119:265-272.
7. Yamagiwa K: Causative factors of gastric cancer; in Yamagiwa K (ed): Gastric Carcinogenesis (in Japanese). Tokyo, Keisei-sha, 1981, pp 213-250.
8. Hauser G: Die krebsige Entartung des chronischen Magen- und Duodenalgeschwürs; in Henke F, Lubarsch O (eds): Handbuch der speziellen pathologischen Anatomie und Histologie. Springer, Berlin, 1926, vol 4/1, pp 497-518.
9. Sakita T, Oguro Y, Takasu S, et al: Observation on the healing of ulcerations in early gastric cancer. The life cycle of the malignant ulcer. Gastroenterology 1971;60:835-844.
10. Correa P: A human model of gastric carcinogenesis. Cancer Res 1988;48:3554-3560.
11. Asaka M, Takeda H, Sugiyama T, et al: What role does Helicobacter pylori play in gastric cancer. Gastroenterology 1997;113:S56-S60.
12. Li QL, Ito K, Sakakura C, et al: Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002;106:113-124.
13. Nomura S, Kaminishi M, Sugiyama K, et al: Clonal analysis of isolated intestinal metaplastic glands of stomach using X linked polymorphism. Gut 1998;42:663-668.
14. Toyota M, Ahuja N, Suzuki H, et al: Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res 1999;59:5438-5442.
15. Kaneda A, Kaminishi M, Yanagihara K, et al: Identification of silencing of nine genes in human gastric cancers. Cancer Res 2002;62:6645-6650.
16. Shimizu N, Ikehara Y, Inada K, et al: Eradication diminishes enhancing effects of Helicobacter pylori infection on glandular stomach carcinogenesis in Mongolian gerbils. Cancer Res 2000;60:1512-1514.
17. Nozaki K, Shimizu N, Ikehara Y, et al: Effect of early eradication on Helicobacter pylori-related gastric carcinogenesis in Mongolian gerbils. Cancer Sci 2003;94:235-239.
18. Kaminishi M, Sadatsuki H, Johjima Y, et al: A new model for production of chronic gastric ulcer by duodenogastric reflux in rats. Gastroenterology 1987;92:1913-1918.
19. Oohara T: Production of experimental chronic gastric ulcer in the rat (in Japanese). Jpn J Cancer Clin 1971;17:457-464.
20. Tatematsu M, Mutai M, Aoki T, et al: Proliferation kinetics of pepsinogen altered pyloric gland cells in rats treated with N-methyl-N′-nitro-N- nitrosoguanidine. Carcinogenesis 1989;10:907-911.
21. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans: Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum 1994;61:1-241.
22. Tatematsu M, Yamamoto M, Shimizu N, et al: Induction of glandular stomach cancers in Helicobacter pylori-sensitive Mongolian gerbils treated with N-methyl-N-nitrosourea and N-methyl-N′-nitro-N-nitrosoguanidine in drinking water. Jpn J Cancer Res 1998;89:97-104.
23. Shimizu N, Inada K, Nakanishi H, et al: Helicobacter pylori infection enhances glandular stomach carcinogenesis in Mongolian gerbils treated with chemical carcinogens. Carcinogenesis 1999;20:669-676.
24. Yamachika T, Nakanishi H, Inada K, et al: N-methyl-N-nitrosourea concentration-dependent, rather than total intake-dependent, induction of adenocarcinoma in the glandular stomach of BALB/c mice. Jpn J Cancer Res 1998;89:385-391.
25. Sipponen P, Correa P: Delayed rise in incidence of gastric cancer in females results in unique sex ratio (M/F) pattern: etiologic hypothesis. Gastric Cancer 2002;5:213-219.
26. Asai K, Hiki N, Mimura Y, et al: Gender differences in cytokine secretion by human peripheral blood mononuclear cells: role of estrogen in modulating LPS-induced cytokine secretion in an ex vivo septic model. Shock 2001;16:340-343.
27. Nomura S, Nakajima A, Osawa E, et al: Gastric expression of peroxisome proliferator-activated receptorγ (PPARγ) in gastritis, and gastric tumors. Gastroenterology 2001;120(suppl 1):A64.
28. Lu J, Imamura K, Nomura S, et al: Chemopreventive effect of peroxisome proliferator-activated receptor gamma on gastric carcinogenesis in mice. Cancer Res 2005;65:4769-4774.